Form 4: Columbia Financial, Inc. CEO Thomas J. Kemly Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Thomas J. Kemly, President & CEO of Columbia Financial, Inc., reports transactions involving common stock and stock options, including acquisitions through a stock-based deferral plan and vesting of stock options.
Summary
- On February 21, 2025, Thomas J. Kemly, the President & CEO of Columbia Financial, Inc., reported changes in beneficial ownership.
- Kemly acquired 116.1983 shares of common stock at $15.38 through a stock-based deferral plan.
- Following the reported transactions, Kemly directly owns 224,860 shares of common stock.
- Kemly also indirectly owns shares through various plans including a Stock-Based Deferral Plan (61,845.946 shares), 401(k) (40,946 shares), ESOP (6,451 shares), SERP (30,157 shares), SIM (41,572 shares), and through his spouse (5,933 shares).
- He also indirectly owns shares through Stock Award II (47,752 shares) and Stock Award III (55,293 shares).
- Kemly holds options to buy 656,471 shares at $15.60 (fully vested), 37,894 shares at $15.94 (vesting from May 1, 2024), and 37,168 shares at $16.49 (vesting from March 6, 2025).
Sentiment
Score: 6
Explanation: The sentiment is neutral as it's a standard regulatory filing. The CEO's stock acquisitions are a mildly positive signal.
Positives
- The CEO's participation in the stock-based deferral plan indicates confidence in the company's future performance.
- The vesting of stock options aligns the CEO's interests with those of the shareholders.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules of stock options and awards suggest a multi-year horizon for executive compensation.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Monitoring these filings can offer insights into management's sentiment and potential future performance.
Stakeholder Impact
- Shareholders can use this information to understand the CEO's alignment with their interests.
- Employees participating in the ESOP and other stock-based plans are indirectly affected by these transactions.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Date of grant for stock options exercisable until 07/23/2029. |
| 05/01/2024 | Commencement date for vesting of stock awards and stock options. |
| 02/21/2025 | Date of the reported transaction. |
| 03/06/2025 | Commencement date for vesting of stock awards and stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.